Work

The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels

Year: 2012

Type: article

Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

DOI: 10.1016/j.bbadis.2012.02.015

Authors: Robert M. Sargis, Brian A. Neel, Clifton O. Brock, Yuxi Lin, Allison T. Hickey, Daniel A. Carlton, Matthew J. Brady

Institution: University of Chicago

Language: English

Topic: Effects and risks of endocrine disrupting chemicals

Subfield: Health, Toxicology and Mutagenesis

Field: Environmental Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, Diabetes Research and Training Center, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences

Awards: Cardiovascular Pathophysiology and Biochemisty Training Program, G4334544061, Environmental Endocrine Disruption of Adipocyte Metabolism, Short Term Training: Health Professional Students, Diabetes Research and Training Center, Environmental Endocrine Disruptors and Adipocyte Biology, G9000001850

OpenAlex ID: W2066529358

FWCI: 5.092

Cites: 38

Cited by: 65

Related to: 10